KWS SAAT

KWS will publish its 2025/26 figures on 23 September and, according to its forecast, expects revenue at the previous year’s level and an EBITDA margin of 19–21 percent. In the first nine months, revenue remained stable at €1,348.6 million and net profit after tax rose 8.5 percent to €220 million. The drought, declared a crisis nationwide, could prompt farmers to choose higher‑performing, more resilient seed and thus give KWS market share; indications of this could appear in the outlook for 2026/27. » More on finanzen.net

Baader Bank has raised its target price for KWS Saat from 78 to 85 euros and kept the rating at 'Add'. As a new competitor, Vylor, a spin-off of Corteva, could become the strongest challenger in the fourth quarter of 2026. Greater transparency about competitors' seed activities is likely to increase KWS's value. » More on finanzen.net

The EU Parliament did not push through a previously discussed patent ban for genetically modified seed, which protects KWS Saat’s international patents. Investors view this as a positive mid-term impulse, while higher seed prices could result from licensing fees for patent holders. The KWS share has been under pressure since May and is trading at a technical support level near €66. » More on finanzen.net